[Drug approval: Olaparib - metastatic castration-resistant prostate cancer with BRCA mutation].

xlomafota13 shared this article with you from Inoreader [Drug approval: Olaparib - metastatic castration-resistant prostate cancer with BRCA mutation]. Via Association française pour l'étude du cancer Related Articles [Drug approval: Olaparib - metastatic castration-resistant prostate cancer with BRCA mutation]. Bull Cancer. 2021 Feb 02;: Authors: Saillant A, Flippot R PMID: 33546874 [PubMed - as supplied by publisher] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.